出典:Inagaki, N., Takeuchi, M., Oura, T., Imaoka, T., & Seino, Y. et al. (2022). Efficacy and safety of tirzepatide monotherapy compared with dulaglutide in Japanese patients with type 2 diabetes (SURPASS J-mono): a double-blind, multicentre, randomised, phase 3 trial. The Lancet D iabetes & Endocrinology, 10(9), 623-633.